SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-265193
Filing Date
2024-11-25
Accepted
2024-11-25 16:27:00
Documents
18
Period of Report
2024-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d886997d8k.htm   iXBRL 8-K 34581
2 EX-4.1 d886997dex41.htm EX-4.1 82105
3 EX-4.2 d886997dex42.htm EX-4.2 84946
4 EX-10.1 d886997dex101.htm EX-10.1 41332
5 EX-99.1 d886997dex991.htm EX-99.1 9136
9 GRAPHIC g886997g1125224013734.jpg GRAPHIC 3765
  Complete submission text file 0001193125-24-265193.txt   450326

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA apto-20241121.xsd EX-101.SCH 2878
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE apto-20241121_lab.xml EX-101.LAB 17995
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apto-20241121_pre.xml EX-101.PRE 11280
20 EXTRACTED XBRL INSTANCE DOCUMENT d886997d8k_htm.xml XML 3656
Mailing Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6
Business Address 66 WELLINGTON STREET WEST, SUITE 5300 TD BANK TOWER BOX 48 TORONTO A6 M5K 1E6 310-849-8060
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 241496276
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)